An Australian government agency (IP Australia) has developed and released a new search system for Australian patents. This system is named as "Auspat".

French court convicted eBay, an online auction and shopping website for selling on its website three Hermes bags that includes two fakes, for a total of 3,000 euros.

The Trademark Electronic Search System (TESS) of USPTO has been updated by addition of two new features, the "Image List" and the "Multiple Searching Ability".

The last EU Competitiveness Council meet was held on 29th and 30th May, 2008 in Brussels. The Council recognized the importance of effective management and protection of Intellectual Property and adopted a resolution and conclusions for the same.

Global and Indian generic companies are in a hurry to seek patents for drug in India. Majority of these applications are for process and composition patents.

A suit on copyright violation against Kolkata Knight Riders (KKR) was filed on May 14th, 2008 by The Indian Performing Rights Society (IPRS).

The Tirumala Tirupati Devasthanam (TTD), that manages the very old hill temple, has made application to the Registry of Geographical Indications (GI), Chennai for its famous and tasty laddu and is now waiting for patent rights.

The Coordination Committee of the World Intellectual Property Organization (WIPO) nominated Mr. Francis Gurry as a candidate for the fourth Director General of WIPO.

An agreement for undertaking drug discovery research and generating Intellectual Property (IP) came into force in the last week of May between GVK Bio, a Hyderabad-based company and Wyeth Pharmaceuticals

BCCI filed a petition against Rediff.com to restrain it from hosting an online cricket game "Indian Fantasy League" due to the similarity in the name and style with "Indian Premier League" and also for using a logo similar to that of IPL.

The Delhi High Court has passed an interim order restraining K.K. Lamps, a Delhi based company from manufacturing GLS lamps under the brand name 'Safelite' or any similar brand name.

An Australian court passed a favourable order for Ranbaxy Laboratories in its patent proceedings against Pfizer with regard to 'Atorvastatin', a cholesterol-lowering drug.

According to China Intellectual Property Office's website, the patients in the country are demanding for compulsory licensing for allowing the domestic companies to manufacture the medicine 'Lamivudine' and market it at a lower price.